Literature DB >> 17507165

Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei.

A L Halberstadt1, C D Balaban.   

Abstract

It is well known that the dorsal raphe nucleus (DRN) sends serotonergic and nonserotonergic projections to target regions in the brain stem and forebrain, including the vestibular nuclei. Although retrograde tracing studies have reported consistently that there are differences in the relative innervation of different target regions by serotonergic and nonserotonergic DRN neurons, the relative termination patterns of these two projections have not been compared using anterograde tracing methods. The object of the present investigation was to trace anterogradely the individual serotonergic and nonserotonergic components of the projection from DRN to the vestibular nuclei in rats. To trace nonserotonergic DRN projections, animals were pretreated with the serotonergic neurotoxin 5,7-dihydroxytryptamine (5,7-DHT), and then, after 7 days, the anterograde tracer biotinylated dextran amine (BDA) was iontophoretically injected into the DRN. In animals treated with 5,7-DHT, nonserotonergic BDA-labeled fibers were found to descend exclusively within the ventricular plexus and to terminate predominantly within the periventricular aspect of the vestibular nuclei. Serotonergic DRN projections were traced by injecting 5,7-DHT directly into DRN, and amino-cupric-silver staining was used to visualize the resulting pattern of terminal degeneration. Eighteen hours after microinjection of 5,7-DHT into the DRN, fine-caliber degenerating serotonergic terminals were found within the region of the medial vestibular nucleus (MVN) that borders the fourth ventricle, and a mixture of fine- and heavier-caliber degenerating serotonergic terminals was located further laterally within the vestibular nuclear complex. These findings indicate that fine-caliber projections from serotonergic and nonserotonergic DRN neurons primarily innervate the periventricular regions of MVN, whereas heavier-caliber projections from serotonergic DRN neurons innervate terminal fields located in more lateral regions of the vestibular nuclei. Thus, serotonergic and nonserotonergic DRN axons target distinct but partially overlapping terminal fields within the vestibular nuclear complex, raising the possibility that these two DRN projection systems are organized in a manner that permits regionally-specialized regulation of processing within the vestibular nuclei.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507165      PMCID: PMC2093990          DOI: 10.1016/j.neuroscience.2007.03.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  86 in total

1.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

2.  5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.

Authors:  A Björklund; H G Baumgarten; A Rensch
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

3.  Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat.

Authors:  M L Kirifides; K L Simpson; R C Lin; B D Waterhouse
Journal:  J Comp Neurol       Date:  2001-07-02       Impact factor: 3.215

4.  Pharmacological characterization and visualization of the glial serotonin transporter.

Authors:  M Inazu; H Takeda; H Ikoshi; M Sugisawa; Y Uchida; T Matsumiya
Journal:  Neurochem Int       Date:  2001-07       Impact factor: 3.921

5.  Axonal transport in serotonin neurons of the midbrain raphe.

Authors:  A E Halaris; B E Jones; R Y Moore
Journal:  Brain Res       Date:  1976-05-14       Impact factor: 3.252

6.  Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin.

Authors:  Kirsten Nielsen; Dorte Brask; Gitte M Knudsen; Susana Aznar
Journal:  Synapse       Date:  2006-04       Impact factor: 2.562

7.  Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus.

Authors:  Rongjian Liu; Yuqiang Ding; George K Aghajanian
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

8.  Differential expression of nitric oxide in serotonergic projection neurons: neurochemical identification of dorsal raphe inputs to rodent trigeminal somatosensory targets.

Authors:  Kimberly L Simpson; Barry D Waterhouse; Rick C S Lin
Journal:  J Comp Neurol       Date:  2003-11-24       Impact factor: 3.215

9.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

Review 10.  Neural substrates linking balance control and anxiety.

Authors:  Carey D Balaban
Journal:  Physiol Behav       Date:  2002-12
View more
  15 in total

1.  Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications.

Authors:  Carey D Balaban; Rolf G Jacob; Joseph M Furman
Journal:  Expert Rev Neurother       Date:  2011-03       Impact factor: 4.618

2.  Abnormalities of vestibular-evoked myogenic potentials in idiopathic Parkinson's disease are associated with clinical evidence of brainstem involvement.

Authors:  Edoardo R de Natale; Francesca Ginatempo; Kai S Paulus; Giovanni M Pes; Andrea Manca; Eusebio Tolu; Virgilio Agnetti; Franca Deriu
Journal:  Neurol Sci       Date:  2015-01-08       Impact factor: 3.307

Review 3.  Gene transfer in the nervous system and implications for transsynaptic neuronal tracing.

Authors:  Youngbuhm Huh; Myung S Oh; Pierre Leblanc; Kwang-Soo Kim
Journal:  Expert Opin Biol Ther       Date:  2010-05       Impact factor: 4.388

4.  Sacculocolic reflex in patients with dementia: is it possible to use it for early diagnosis?

Authors:  Leman Birdane; Armagan Incesulu; Melek Kezban Gurbuz; Demet Ozbabalik
Journal:  Neurol Sci       Date:  2011-05-11       Impact factor: 3.307

5.  Neuropharmacology of vestibular system disorders.

Authors:  Enrique Soto; Rosario Vega
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 6.  Top-down approach to vestibular compensation: translational lessons from vestibular rehabilitation.

Authors:  Carey D Balaban; Michael E Hoffer; Kim R Gottshall
Journal:  Brain Res       Date:  2012-09-06       Impact factor: 3.252

7.  Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala.

Authors:  Adam L Halberstadt; Carey D Balaban
Journal:  J Chem Neuroanat       Date:  2008-03-08       Impact factor: 3.052

8.  Dorsal raphe neuronal activities are modulated by methylphenidate.

Authors:  Bin Tang; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2012-12-27       Impact factor: 3.575

9.  Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson's Disease.

Authors:  Ali Soliman Shalash; Dalia Mohamed Hassan; Hanan Hani Elrassas; Mohamed Mosaad Salama; Edna Méndez-Hernández; José M Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2017-02-27       Impact factor: 4.003

10.  Identification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulation.

Authors:  Carey D Balaban; Sarah W Ogburn; Susan G Warshafsky; Abdul Ahmed; Bill J Yates
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.